ResMed Inc. (RMD) is a publicly traded Healthcare sector company. As of October 15, 2026, RMD trades at $241.42 with a market cap of $33.06B and a P/E ratio of 20.91. RMD moved +2.68% today. Year to date, RMD is -3.89%; over the trailing twelve months it is -12.88%. Its 52-week range spans $180.27 to $293.81. Analyst consensus is buy with an average price target of $242.91. Rallies surfaces RMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ResMed Inc. (RMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RMD moved +2.68% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $241.42 |
| Market Cap | $33.06B |
| P/E Ratio | 20.91 |
| EPS | $10.47 |
| Dividend Yield | 0.66% |
| 52-Week High | $293.81 |
| 52-Week Low | $180.27 |
| Volume | 337.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.65B |
| Net Income | $1.52B |
| Gross Margin | 61.06% |
14 analysts cover RMD: 0 strong buy, 5 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $242.91.